Atlas Trials

Study of Arimoclomol in Patients Diagnosed With Gaucher Disease Type 1 or 3

Clinical trial NCT03746587 · TERMINATED

Trial details

NCT number
NCT03746587
Sponsor
ZevraDenmark
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Gaucher Disease, Type 1Gaucher Disease, Type 3
Start date
2018-06-06
Primary completion
2020-04-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.